國立高雄大學圖資館 |

Language: English

Back

Pediatric pharmacotherapy

Anker, Johannes van den.

Pediatric pharmacotherapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pediatric pharmacotherapyedited by Wieland Kiess, Matthias Schwab, Johannes van den Anker.
other author:	Kiess, Wieland.
Published:	Cham :Springer International Publishing :2020.
Description:	viii, 538 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Pediatric pharmacology.
Online resource:	https://doi.org/10.1007/978-3-030-50494-6
ISBN:	9783030504946$q(electronic bk.)

Pediatric pharmacotherapy
Pediatric pharmacotherapy[electronic resource] /edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker. - Cham :Springer International Publishing :2020. - viii, 538 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2610171-2004 ;. - Handbook of experimental pharmacology ;208..

Anti-epileptic drugs in pediatrics -- Current and new therapies for Duchenne Muscular Dystrophy -- Lysosomal diseases -- Mitochondriopathies -- Endocrinology thyroid, pituitary, growth stimulant, growth reduction -- Bone disease - bisphosphonates -- Diabetes type 1 and 3 (insulin; sulfonylurea; others) -- Diabetes type 2 (metformin etc.) -- Dermatology - part 1 urticaria, atopic dermatitis -- Dermatology part 2, ichtyosis, psoriasis -- Cardiovascular part 1- catcholamines, inotropic -- Cardiovascular part 2 - antiarhythmica, anti hypertensives -- Nephrology - dialysis -- How to use drugs in obese children and adolescents -- Haematology - CSFs, erythropoietin -- Antiretroviral/HIV -- Clinical pharmacology and pharmacometrics to better understand physiological changes during pregnancy and neonatal life -- Antihelminth treatment -- Inflammatory bowel disease -- Constipation; laxatives -- Psychiatric diseases in children and adolescents -- Oncology - cell reducing agents part 1, part 2, part 3 -- Immunosuppressants - organ transplantation -- Bone marrow/stem cell transplantation -- Narcotic sparing approaches and the shift towards paracetamol in neonatal intensive care -- Disorders of puberty: pharmacotherapeutic strategies for management.

This volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.

ISBN: 9783030504946$q(electronic bk.)

Standard No.: 10.1007/978-3-030-50494-6doiSubjects--Topical Terms:

459260
Pediatric pharmacology.

LC Class. No.: RJ560 / .P435 2020

Dewey Class. No.: 615.1083

Pediatric pharmacotherapy
LDR:03387nmm a2200337 a 4500 001 583323
003 DE-He213
005 20201106142701.0
006 m d
007 cr nn 008maaau
008 210202s2020 sz s 0 eng d
020 $a 9783030504946$q(electronic bk.)
020 $a 9783030504939$q(paper)
024 7 $a 10.1007/978-3-030-50494-6 $2 doi
035 $a 978-3-030-50494-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RJ560 $b .P435 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.1083 $2 23
090 $a RJ560 $b .P371 2020
245 0 0 $a Pediatric pharmacotherapy $h [electronic resource] / $c edited by Wieland Kiess, Matthias Schwab, Johannes van den Anker.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a viii, 538 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.261
505 0 $a Anti-epileptic drugs in pediatrics -- Current and new therapies for Duchenne Muscular Dystrophy -- Lysosomal diseases -- Mitochondriopathies -- Endocrinology thyroid, pituitary, growth stimulant, growth reduction -- Bone disease - bisphosphonates -- Diabetes type 1 and 3 (insulin; sulfonylurea; others) -- Diabetes type 2 (metformin etc.) -- Dermatology - part 1 urticaria, atopic dermatitis -- Dermatology part 2, ichtyosis, psoriasis -- Cardiovascular part 1- catcholamines, inotropic -- Cardiovascular part 2 - antiarhythmica, anti hypertensives -- Nephrology - dialysis -- How to use drugs in obese children and adolescents -- Haematology - CSFs, erythropoietin -- Antiretroviral/HIV -- Clinical pharmacology and pharmacometrics to better understand physiological changes during pregnancy and neonatal life -- Antihelminth treatment -- Inflammatory bowel disease -- Constipation; laxatives -- Psychiatric diseases in children and adolescents -- Oncology - cell reducing agents part 1, part 2, part 3 -- Immunosuppressants - organ transplantation -- Bone marrow/stem cell transplantation -- Narcotic sparing approaches and the shift towards paracetamol in neonatal intensive care -- Disorders of puberty: pharmacotherapeutic strategies for management.
520 $a This volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.
650 0 $a Pediatric pharmacology. $3 459260
650 0 $a Children $x Diseases $x Chemotherapy. $3 459262
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Pediatrics. $3 274247
700 1 $a Kiess, Wieland. $3 873853
700 1 $a Schwab, Matthias. $3 524212
700 1 $a Anker, Johannes van den. $3 873854
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-50494-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)